ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Secretive startup will use gene therapy to reverse aging in dogs—and humans are next – The Daily Dot

Continue reading

2018-05-09 Michael Zand NEWS

Find Pain Relief with Stem Cell Therapy at Balance Wellspace – WSLS 10

Find Pain Relief with Stem Cell Therapy at Balance WellspaceWSLS 10Find Pain Relief with Stem Cell Therapy at Balance Wellspace. Hear about the success Balance Wellspace is seeing with patients managing pain. By Natalie Faunce – Daytime Blue Ridge Host… Continue reading

2018-05-09 Michael Zand NEWS

Study: Crowdfunding campaigns for stem cell treatments ‘potentially misleading’ – Becker’s Hospital Review


The Daily Dot

Secretive startup will use gene therapy to reverse aging in dogs—and humans are next
The Daily Dot
Advances in gene therapy are bringing us closer to immortality, and now one of the world’s most influential scientists is on the job. Renowned geneticist George Church, who pioneered the use of CRISPR to edit the genes of human cells, wants to reverse …

Continue reading

2018-05-09 Michael Zand NEWS

CAR T Therapy Case Study Shows Early Success in Treatment of Acute Myeloid Leukemia – AJMC.com Managed Markets Network

Study: Crowdfunding campaigns for stem cell treatments ‘potentially misleading’
Becker’s Hospital Review
Nearly 44 percent of the 408 campaigns “made statements that were definitive or certain” about the stem cell treatment’s effectiveness, while more than 30 percent “made statements optimistic or hopeful about efficacy,” according to the study. More than …
Crowdfunding Exaggerates Efficacy of Unproven Stem Cell TxMonthly Prescribing Reference

all 4 news articles »

Continue reading

2018-05-09 Michael Zand NEWS

What is CRISPR and could it be used by criminals to alter their DNA? – iNews


Medical Xpress

CAR T Therapy Case Study Shows Early Success in Treatment of Acute Myeloid Leukemia
AJMC.com Managed Markets Network
In a new phase 1 trial called THINK (Therapeutic Immunotherapy with Natural Killer Group 2D [NKG2D]), published online in Haematologica, researchers are investigating Celyad’s new CAR T therapy CYAD-01 in the treatment of acute myeloid leukemia (AML …
New CAR T case study shows promise in acute myeloid leukemiaMedical Xpress

all 2 news articles »

Continue reading

2018-05-09 Michael Zand NEWS

What is CRISPR and could it be used by criminals to alter their DNA? – iNews


iNews

What is CRISPR and could it be used by criminals to alter their DNA?
iNews
CRISPR is a revolutionary genetic editing technique that’s been hailed a game-changer in science. The method allows scientists to effectively ‘cut and paste’ small sections of DNA out of a genome and replace or delete harmful genes. It’s believed it …

Continue reading

2018-05-09 Michael Zand NEWS

An Inside Look at CAR-T, Gene Therapy Launches at ‘What’s Hot’ May 16 – Xconomy


iNews

What is CRISPR and could it be used by criminals to alter their DNA?
iNews
CRISPR is a revolutionary genetic editing technique that’s been hailed a game-changer in science. The method allows scientists to effectively ‘cut and paste’ small sections of DNA out of a genome and replace or delete harmful genes. It’s believed it …

Continue reading

2018-05-09 Michael Zand NEWS

New gene therapy sparks healthy heart beats – EurekAlert (press release)

New gene therapy sparks healthy heart beatsEurekAlert (press release)Michael Kotlikoff, provost of Cornell University and a professor of molecular physiology, is part of an international collaboration that is aiming to bridge that gap in damaged hearts… Continue reading

2018-05-09 Michael Zand NEWS
  • 1
  • …
  • 124
  • 125
  • 126
  • 127
  • 128
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

An Inside Look at CAR-T, Gene Therapy Launches at ‘What’s Hot’ May 16
Xconomy
Xconomy Boston —. Getting a new drugmaking technology through clinical development and to market is a major milestone, the culmination of years of scientific work. But the true test of how important that technology is comes afterwards, when the real …